Literature DB >> 27221082

Expression of cysteinyl leukotriene receptor 1 and 2 (CysLTR1 and CysLTR2) in the lymphocytes of hyperplastic tonsils: comparison between allergic and nonallergic snoring children.

Bruno Peres Paulucci1, Juliana Pereira2, Patricia Picciarelli3, Debora Levy4, Renata Cantisani Di Francesco5.   

Abstract

BACKGROUND: Cysteinyl leukotriene receptor 1 and 2 (CysLTR1 and CysLTR2) are involved in allergic processes and play a role in adenotonsillar hyperplasia (AH). Clinically, only CysLTR1 may be blocked by montelukast. Our objective was to compare the expression of CysLTR1 and CysLTR2 in the B and T cells of hyperplasic tonsils of sensitized (SE) and control (NS) snoring children.
METHODS: Sixty children, 5 to 10 years of age, referred for adenotonsillectomy, were divided into SE and NS groups, according to their responses to the skin-prick test. Cells from the removed tissues were stained for CysLTR1, CysLTR2, CD19, and CD3 and counted via flow cytometry. messenger RNA (mRNA) expression of the CysLTRs genes was measured real-time quantitative reverse transcription polymerase chain reaction (RT-qPCR).
RESULTS: The SE group showed reduced expression of the small CD3+/CysLTR1+ lymphocytes (4.6 ± 2.2 vs 6.5 ± 5.0; p = 0.04). Regarding the large lymphocytes, the SE group showed lower expression of CD3+/CysLTR1+ (40.9 ± 14.5 vs 47.6 ± 11.7; p = 0.05), CD19+/CysLTR1+ (44.6 ± 16.9 vs 54.1 ± 12.4; p = 0.01), and CD19+/CysLTR2+ (55.3 ± 11.3 vs 61.5 ± 12.6; p = 0.05) lymphocytes. Considering the total number of lymphocytes, the SE group had fewer CD3+/CysLTR1+ lymphocytes (11.1 ± 5.5 vs 13.7 ± 6.2; p = 0.04). All other cell populations exhibited reduced expression in the SE group without statistical significance. The expression of CysLTR2 was significantly higher (p < 0.05) than CysLTR1 in most studied cell populations. The mRNA expression did not show significant differences between the groups.
CONCLUSION: The expression of CysLTR is higher in the lymphocytes of the NS children, and CysLTR2 shows greater expression than CysLTR1 Respiratory allergies do not appear to be a stimulus for AH occurrence. Newer drugs capable of blocking both CysLTRs warrant further study.
© 2016 ARS-AAOA, LLC.

Entities:  

Keywords:  allergy; cysteinyl leukotriene receptor; hyperplasia; lymphocyte; tonsil

Mesh:

Substances:

Year:  2016        PMID: 27221082     DOI: 10.1002/alr.21798

Source DB:  PubMed          Journal:  Int Forum Allergy Rhinol        ISSN: 2042-6976            Impact factor:   3.858


  2 in total

1.  CYSLTR1 promotes adenoid hypertrophy by activating ERK1/2.

Authors:  Wenjie Gao; Jinying Li; Quanheng Li; Shuhua An
Journal:  Exp Ther Med       Date:  2018-06-08       Impact factor: 2.447

2.  Sleep Apnea and Skin.

Authors:  Vinaya Soundararajan; Jennifer Lor; Anna B Fishbein
Journal:  Curr Sleep Med Rep       Date:  2020-08-25
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.